Exacerbated by the COVID-19 pandemic, the opioid epidemic in the United States is a dangerous reality that affects all demographics. In this presentation, gender differences in opioid use disorders will be discussed from an epidemiologic perspective. Understanding the differences in trends by gender can help clinicians treat the patient, rather than treating the condition. Neurobiological and social determinants will also be reviewed as the differences vary greatly by gender. Finally, treatment implications will be discussed so we can better understand the impact of tailored OUD treatment. Presenter: Kathleen Brady, MD, PhD, Distinguished Professor, Medical University of South Carolina
https://www.psychiatry.org/
